Tectonic Therapeutic, Inc.

Tectonic Therapeutic, Inc.verified

TECX

Price:

$32.985

Market Cap:

$619.35M

Tectonic Therapeutic, Inc., a clinical stage biotechnology company focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G-protein coupled receptors(GPCRs). It offers GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines. The company's pipeline products include RXFP1 agonist, which is in ongoing phase 1a and 1b for the indication of heart failure with preserved ejection fraction; GPCR antagonist for indication of hereditary hemorrhagic telangiectasia; bi-functional GPCR modulator for indication of fibrosis; and GPCR modulators. Tectonic Therapeutic, Inc. is based in Watertown, Massachusetts.

Industry

Biotechnology

IPO Date

2018-06-21

Stock Exchange

NASDAQ

Ticker

TECX

The Enterprise Value as of March 2026 (TTM) for Tectonic Therapeutic, Inc. (TECX) is 366.82M

According to Tectonic Therapeutic, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 366.82M. This represents a change of 506.13% compared to the average of 60.52M of the last 4 quarters.

Tectonic Therapeutic, Inc. (TECX) Historical Enterprise Value (quarterly & annually)

How has TECX Enterprise Value performed in the past?

The mean historical Enterprise Value of Tectonic Therapeutic, Inc. over the last ten years is 321.03M. The current 366.82M Enterprise Value has changed 11.33% with respect to the historical average. Over the past ten years (40 quarters), TECX's Enterprise Value was at its highest in in the March 2018 quarter at 688.90M. The Enterprise Value was at its lowest in in the March 2022 quarter at -88965615.84.

Quarterly (TTM)
Annual

Average

321.03M

Median

257.24M

Minimum

880.68K

Maximum

741.47M

Tectonic Therapeutic, Inc. (TECX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Tectonic Therapeutic, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 3.97%

Maximum Annual Enterprise Value = 741.47M

Minimum Annual Increase = -99.36%

Minimum Annual Enterprise Value = 880.68K

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2025129.69M-76.16%
2024543.93M1.42%
202335.86M3.97%
2022880.68K-99.36%
2021137.98M-43.69%
2020245.03M-32.90%
2019365.17M35.52%
2018269.46M-63.63%
2017740.87M-0.08%

Tectonic Therapeutic, Inc. (TECX) Average Enterprise Value

How has TECX Enterprise Value performed in the past?

The current Enterprise Value of Tectonic Therapeutic, Inc. (TECX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

236.49M

5-year avg

169.67M

10-year avg

321.03M

Tectonic Therapeutic, Inc. (TECX) Enterprise Value vs. Peers

How is TECX’s Enterprise Value compared to its peers?

Tectonic Therapeutic, Inc.’s Enterprise Value is less than Alto Neuroscience, Inc. (659.22M), greater than Larimar Therapeutics, Inc. (293.75M), greater than Cellectis S.A. (298.33M), less than Lyell Immunopharma, Inc. (429.77M), greater than Amarin Corporation plc (194.16M), greater than AC Immune S.A. (233.78M), less than DBV Technologies S.A. (611.17M), less than Alpha Tau Medical Ltd. (619.32M), greater than Silence Therapeutics plc (351.57M), greater than Aldeyra Therapeutics, Inc. (-54510827116779.00),

CompanyEnterprise ValueMarket cap
659.22M$769.51M
293.75M$379.54M
298.33M$347.06M
429.77M$448.03M
194.16M$316.86M
233.78M$324.94M
611.17M$480.23M
619.32M$621.58M
351.57M$363.01M
-54510827116779.00$257.88M

Build a custom stock screener for Tectonic Therapeutic, Inc. (TECX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tectonic Therapeutic, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Tectonic Therapeutic, Inc. (TECX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Tectonic Therapeutic, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Tectonic Therapeutic, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Tectonic Therapeutic, Inc. (TECX)?

What is the 3-year average Enterprise Value for Tectonic Therapeutic, Inc. (TECX)?

What is the 5-year average Enterprise Value for Tectonic Therapeutic, Inc. (TECX)?

How does the current Enterprise Value for Tectonic Therapeutic, Inc. (TECX) compare to its historical average?